File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Induction of KLF2 by Exercise Activates eNOS to Improve Vasodilatation in Diabetic Mice

TitleInduction of KLF2 by Exercise Activates eNOS to Improve Vasodilatation in Diabetic Mice
Authors
Issue Date1-Sep-2023
PublisherAmerican Diabetes Association
Citation
Diabetes, 2023, v. 72, n. 9, p. 1330-1342 How to Cite?
Abstract

UNLABELLED\nARTICLE HIGHLIGHTS\nDiabetic endothelial dysfunction associated with diminished endothelial nitric oxide (NO) synthase (eNOS) activity accelerates the development of atherosclerosis and cardiomyopathy. However, the approaches to restore eNOS activity and endothelial function in diabetes remain limited. The current study shows that enhanced expression of Krüppel-like factor 2 (KLF2), a shear stress-inducible transcription factor, effectively improves endothelial function through increasing NO bioavailability. KLF2 expression is suppressed in diabetic mouse aortic endothelium. Running exercise and simvastatin treatment induce endothelial KLF2 expression in db/db mice. Adenovirus-mediated endothelium-specific KLF2 overexpression enhances both endothelium-dependent relaxation and flow-mediated dilatation, while it attenuates oxidative stress in diabetic mouse arteries. KLF2 overexpression increases the phosphorylation of eNOS at serine 1177 and eNOS dimerization. RNA-sequencing analysis reveals that KLF2 transcriptionally upregulates genes that are enriched in the cyclic guanosine monophosphate-protein kinase G-signaling pathway, cAMP-signaling pathway, and insulin-signaling pathway, all of which are the upstream regulators of eNOS activity. Activation of the phosphoinositide 3-kinase-Akt pathway and Hsp90 contributes to KLF2-induced increase of eNOS activity. The present results suggest that approaches inducing KLF2 activation, such as physical exercise, are effective to restore eNOS activity against diabetic endothelial dysfunction.\nExercise and statins restore the endothelial expression of Krüppel-like factor 2 (KLF2), which is diminished in diabetic db/db mice. Endothelium-specific overexpression of KLF2 improves endothelium-dependent relaxation and flow-mediated dilation through increasing nitric oxide bioavailability. KLF2 promotes endothelial nitric oxide synthase (eNOS) coupling and phosphorylation in addition to its known role in eNOS transcription. KLF2 upregulates the expression of several panels of genes that regulate eNOS activity.


Persistent Identifierhttp://hdl.handle.net/10722/338282
ISSN
2023 Impact Factor: 6.2
2023 SCImago Journal Rankings: 2.541
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLuo, JY-
dc.contributor.authorCheng, CK-
dc.contributor.authorGou, L-
dc.contributor.authorHe, L-
dc.contributor.authorZhao, L-
dc.contributor.authorZhang, Y-
dc.contributor.authorWang, L-
dc.contributor.authorLau, CW-
dc.contributor.authorXu, A-
dc.contributor.authorChen, AF-
dc.contributor.authorHuang, Y-
dc.date.accessioned2024-03-11T10:27:42Z-
dc.date.available2024-03-11T10:27:42Z-
dc.date.issued2023-09-01-
dc.identifier.citationDiabetes, 2023, v. 72, n. 9, p. 1330-1342-
dc.identifier.issn0012-1797-
dc.identifier.urihttp://hdl.handle.net/10722/338282-
dc.description.abstract<p>UNLABELLED\nARTICLE HIGHLIGHTS\nDiabetic endothelial dysfunction associated with diminished endothelial nitric oxide (NO) synthase (eNOS) activity accelerates the development of atherosclerosis and cardiomyopathy. However, the approaches to restore eNOS activity and endothelial function in diabetes remain limited. The current study shows that enhanced expression of Krüppel-like factor 2 (KLF2), a shear stress-inducible transcription factor, effectively improves endothelial function through increasing NO bioavailability. KLF2 expression is suppressed in diabetic mouse aortic endothelium. Running exercise and simvastatin treatment induce endothelial KLF2 expression in db/db mice. Adenovirus-mediated endothelium-specific KLF2 overexpression enhances both endothelium-dependent relaxation and flow-mediated dilatation, while it attenuates oxidative stress in diabetic mouse arteries. KLF2 overexpression increases the phosphorylation of eNOS at serine 1177 and eNOS dimerization. RNA-sequencing analysis reveals that KLF2 transcriptionally upregulates genes that are enriched in the cyclic guanosine monophosphate-protein kinase G-signaling pathway, cAMP-signaling pathway, and insulin-signaling pathway, all of which are the upstream regulators of eNOS activity. Activation of the phosphoinositide 3-kinase-Akt pathway and Hsp90 contributes to KLF2-induced increase of eNOS activity. The present results suggest that approaches inducing KLF2 activation, such as physical exercise, are effective to restore eNOS activity against diabetic endothelial dysfunction.\nExercise and statins restore the endothelial expression of Krüppel-like factor 2 (KLF2), which is diminished in diabetic db/db mice. Endothelium-specific overexpression of KLF2 improves endothelium-dependent relaxation and flow-mediated dilation through increasing nitric oxide bioavailability. KLF2 promotes endothelial nitric oxide synthase (eNOS) coupling and phosphorylation in addition to its known role in eNOS transcription. KLF2 upregulates the expression of several panels of genes that regulate eNOS activity.</p>-
dc.languageeng-
dc.publisherAmerican Diabetes Association-
dc.relation.ispartofDiabetes-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleInduction of KLF2 by Exercise Activates eNOS to Improve Vasodilatation in Diabetic Mice-
dc.typeArticle-
dc.identifier.doi10.2337/db23-0070-
dc.identifier.pmid37347764-
dc.identifier.scopuseid_2-s2.0-85168428487-
dc.identifier.volume72-
dc.identifier.issue9-
dc.identifier.spage1330-
dc.identifier.epage1342-
dc.identifier.eissn1939-327X-
dc.identifier.isiWOS:001193970400018-
dc.identifier.issnl0012-1797-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats